FDA Limits Use Of Johnson & Johnson Vaccine Due To Blood Clot Risk

Moderna and Pfizer’s Covid-19 vaccines are preferable to Johnson & Johnson’s vaccine because they have significantly milder side effects, the Food and Drug Administration said.

Read the full post at Forbes - Healthcare
Vote This Post DownVote This Post Up (No Ratings Yet)
Explore the Archive